1Johnson RJ . New insight into the pathogenesis of pathogenunia. AmJ Kid Dis , 2000,36:214-219.
2Doyonnas R, Kershaw DB, Duhme C, et al. Anuria,omphalocele, and perinatal lethality in miee lacking the CD34 related protein podocalyxin. J Exp Med, 2001,194: 13-27.
3Chen HC, Chen CA, Guh JY, et al. Altering expression of a3β1 integrin on podocyte of human and rats with diabetes. Life Sciences, 2000,67 2345-2353.
4Korhonen M, Ylanne J, Laitinen I., et al. Distribution ofβ1 and β3 integrins in human fetal and adult kidney.Lab Invest, 1990,62:616-625.
5Adler S. Characterization of glomerular epithelial cell matrix receptors. Am J Pathol, 1992,141:571-578.
6Luimula P, Ahola H, Wang SX, et al. Nephrln in experimental glomerular disease. Kidney Int, 2000,58 :1461-1468.
7Boute N, Griboval O, Roselli S, et al. NPHS2,encoding the glomerular protein podocin, ismutated in autosomal recessive steroidresistant nephrotic syndrome. Nat Genet, 2000,24:349-354.
8Nakamura T, Ushlyama C, Suzuki S, et al. Effects of angiotensin converting enzyme inhibitor, angiotensin Ⅱ receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy. Am J Nephrol, 2000, 20: 373-379.
9Kriz W , Gretz N, lenley KV, et al. Progression of glomerular diseases: is the podocyte the culprit?Kidney Int, 1998,54: 687 -697.
10Shankland SJ, Eitner F, Hudkins KL, et al.Differential expression of cyclin-dependent kinase rinhibitors in human glomerular dlsease: role in podocyte proliferation and maturation. Kidney Int,2000, 58: 674-683.
